Fair Seeds for Farmers Act
- Sponsor
- Rep. McGovern, James P. [D-MA-2]
- Committees
- Judiciary Committee (primary)
- Last action
- Jul 14, 2026
Bottom line
The Fair Seeds for Farmers Act aims to enhance farmer and researcher autonomy by restricting intellectual property rights and associated contractual limitations on plant genetic material, potentially increasing access to seeds and fostering agricultural innovation outside of proprietary controls.
What it actually does
This bill amends the Leahy-Smith America Invents Act to significantly narrow the scope of intellectual property protection for plants, plant varieties, and plant germplasm. It specifies that federal IP protection for these materials can only be granted under the Plant Variety Protection Act or the Plant Patent Act of 1930. Crucially, it prohibits the enforcement of any contractual obligations or agreements that limit the use of protected plant material for research, breeding, experimentation, seed saving, or propagation.
Proponents argue
Proponents argue that this bill is essential for promoting fair competition in the seed market, reducing costs for farmers, and fostering agricultural innovation by ensuring broader access to plant genetic resources. They contend that current broad intellectual property protections and restrictive seed contracts stifle independent research, limit farmers' traditional right to save and replant seeds, and contribute to monopolistic practices by large seed companies, ultimately harming food security and farmer livelihoods.
Opponents contend
Opponents contend that this legislation would severely undermine the intellectual property rights that incentivize significant private investment in plant breeding and agricultural biotechnology. They argue that weakening these protections would disincentivize innovation, reduce the development of new, improved crop varieties, and ultimately harm the competitiveness of U.S. agriculture by making it less attractive for companies to invest in research and development.
The bill is very short and straightforward, allowing for a quick and easy read to understand its core provisions.
Section 2(1), amending Leahy-Smith America Invents Act, Section 33 heading
Clarification of Section 33 Heading
This provision amends the heading of Section 33 of the Leahy-Smith America Invents Act to explicitly state 'for human organisms'. This change clarifies that the existing prohibition on patenting human organisms applies specifically to human organisms, setting the stage for the subsequent section which addresses plants.
Supporters argue
Proponents would argue this is a technical clarification that improves the precision of the law's language, ensuring that the intent of Section 33 is clearly understood as applying solely to human organisms.
Critics contend
No specific opposition is typically raised against this provision as it is a technical, clarifying amendment rather than a substantive policy change.
Tradeoffs
This provision primarily serves a clarifying function and does not introduce significant policy tradeoffs on its own.
Section 2(2), adding new Section 33A(a)(1)
Limitation on Federal IP Protection for Plants
This provision establishes that federal intellectual property protection for any plant, plant variety, or plant germplasm can only be provided under specific laws: the Plant Variety Protection Act or the Plant Patent Act of 1930. This means that other forms of intellectual property, such as utility patents, would no longer be applicable to plants, effectively narrowing the avenues for proprietary control over plant genetic material.
Section 2(2), adding new Section 33A(a)(2)
Prohibition on Enforcement of Restrictive Plant Contracts
This provision explicitly states that no contractual obligation or agreement that limits the use of a plant, plant variety, plant germplasm, or other biological material for research, breeding, experimentation, seed saving, or propagation may be enforced. This directly targets common 'technology use agreements' or 'grower agreements' used by seed companies that restrict farmers from saving seeds or using patented traits for further breeding, even if the underlying IP is covered by the Plant Variety Protection Act or Plant Patent Act.
Section 2(2), adding new Section 33A(d)
Effective Date and Applicability
This provision specifies that the new limitations on intellectual property protection for plants will apply to any patent application that is pending on, or filed on or after, the date the Act is enacted. It also applies to any contractual obligation or agreement entered into on or after the date of enactment. However, it explicitly states that the Act will not affect the validity of any patents issued on applications filed before this new effective date.
While the bill states 'no protection may be provided under any Federal law with respect to a plant...', it immediately follows with 'except pursuant to a law described in subsection (b)'. Subsection (b) then lists the Plant Variety Protection Act and Chapter 15 of title 35 (Plant Patent Act of 1930). This means the bill does not eliminate all IP protection for plants but specifically limits it to these two existing frameworks, effectively excluding utility patents for plants.
Section 2(2), adding new Section 33A(a)(1) and (b)
Why it matters:This structure is a common legislative technique to state a general rule and then immediately provide exceptions, which can make the precise scope of the change less obvious on a first read. It is not necessarily evasive but requires careful reading.
Case for: Supporters would argue this approach ensures that appropriate, specialized IP protections for plants remain, while preventing the application of broader patent law that they believe is ill-suited for biological entities and can lead to monopolistic control.
Case against: Critics might argue that by framing it as a broad prohibition with exceptions, the bill downplays the significant impact of removing utility patent eligibility for plants, which they see as a critical form of protection for their innovations.
Estimated impact: This clarification defines the core shift in intellectual property law for plants, significantly altering the legal landscape for plant breeders and farmers by removing utility patents as an option for new plant varieties.
The bill explicitly invalidates 'any contractual obligation or agreement... that limits the use of a plant, plant variety, plant germplasm, or other biological material for research, breeding, experimentation, seed saving, or propagation'. This goes beyond merely limiting patent eligibility and directly targets private contracts, which are a primary mechanism for seed companies to control the use of their proprietary seeds, even those protected under PVPA.
Section 2(2), adding new Section 33A(a)(2)
Why it matters:This is a direct and intentional policy choice, not necessarily buried evasively, but its broad reach into private agreements is a significant legal intervention that may not be immediately grasped as distinct from the IP limitations.
Case for: Proponents argue that this provision is crucial to prevent seed companies from circumventing the spirit of IP limitations through contractual means, ensuring that farmers truly regain the freedom to save seeds and that researchers have access to genetic material.
Case against: Opponents argue that this is an unprecedented governmental interference in private contracts, undermining the freedom of parties to negotiate terms and potentially leading to a 'tragedy of the commons' where valuable genetic material is exploited without fair compensation to its developers.
Estimated impact: This provision would fundamentally alter the business model of many seed companies, potentially leading to significant changes in seed pricing, distribution, and research funding, while empowering farmers with greater autonomy over their crops.